“New” Antigenic Targets and Methodological Approaches for Refining Laboratory Diagnosis of Antiphospholipid Syndrome
Antiphospholipid antibodies (aPLs) are a heterogeneous group of antibodies directed against phospholipids or protein/phospholipid complexes. Currently, aPLs are assessed using either “solid-phase” assays that identify anticardiolipin antibodies and anti-β2-glycoprotein I antibodies or “liquid-phase”...
Saved in:
| Main Authors: | Roberta Misasi, Antonella Capozzi, Agostina Longo, Serena Recalchi, Emanuela Lococo, Cristiano Alessandri, Fabrizio Conti, Guido Valesini, Maurizio Sorice |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2015/858542 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Mosaic of “Seronegative” Antiphospholipid Syndrome
by: Fabrizio Conti, et al.
Published: (2014-01-01) -
Elevated Serum Level of HMGB1 in Patients with the Antiphospholipid Syndrome
by: Valeria Manganelli, et al.
Published: (2017-01-01) -
Altered Traffic of Cardiolipin during Apoptosis: Exposure on the Cell Surface as a Trigger for “Antiphospholipid Antibodies”
by: Valeria Manganelli, et al.
Published: (2015-01-01) -
Wnt signaling as a translational target in rheumatoid and psoriatic arthritis
by: Gloria Riitano, et al.
Published: (2025-02-01) -
Extracellular Vesicles in the Crosstalk of Autophagy and Apoptosis: A Role for Lipid Rafts
by: Agostina Longo, et al.
Published: (2025-05-01)